CliffordGeorgeAndrewMDPhD, MSTP

Neurology • Severna Park, MD

Neurodegenerative, Dementia & Geriatrics

Clifford G. Andrew, M.D., PH.D.

Join to view full profile

Dr. Andrew is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Andrew's full profile

Already have an account?

Office
CLOSED
Severna Park MD
Severna Park, MD 21146

Summary

Attended the Medical Scientist Training Program at Duke:

July 1968: Enrolled in MSTP with Medical School Class of 1972

July 1968-June 1970: Medical School Basic and Clinical Required Coursework

July 1970-June 1974: Graduate School Biochemistry and Basic Elective Coursework.

July 1974-June 1975: Medical School Clinical Elective Coursework.

June 1974: Ph.D. Completed.

June 1975: M.D. and M.S.T.P. Completed.

Education & Training

Johns Hopkins UniversityResidency, Neurology, 1976 - 1980
Duke University HospitalInternship, Internal Medicine, 1975 - 1976
Duke University School of MedicineClass of 1975, M.D.
Duke University School of Graduate StudiesMSTP, Medical Scientist, 1975
Duke University School of Graduate StudiesPhD, Biochemistry, 1974

Certifications & Licensure

MD State Medical License 1979 - 2024
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Readers Choice 1st Place Winner Neurology Annapolis Capital Newspaper, 2014
Readers Choice 1st Place Winner Neurology Maryland Gazette Newspaper, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

289 citations
Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine Receptors
Richard R. Almon, C.G. Andrew, Stanley H. Appel
Science. 1974-10-04
43 citations
Acetylcholine receptor in normal and denervated slow and fast muscle.
Richard R. Almon, C.G. Andrew, Stanley H. Appel
Biochemistry. 1974-12-01
7 citations
Susceptibility of skeletal muscle to coxsackie A2 virus infection: effects of botulinum toxin and denervation
Clifford G. Andrew, Daniel B. Drachman, Alan Pestronk, Opendra Narayan
Science. 1984-02-17

Journal Articles

Sexual Recognition in Adult Erythemis simplicicollis
Clifford G Andrew, The Ohio Journal of Science, 66: 613-617, 11/1/1966
Macromolecular Characterization of Muscle Membranes I. Proteins and Sialic Acid of Normal and Denervated Muscle
Clifford G Andrew, Stanley H Appel, The Journal of Biological Cemistry, 248: 5156-5163, 7/25/1973
Phosphorylation of Muscle Membranes: Identification of a Membrane-Bound Protein Kinase
Clifford G Andrew, Alan D Roses, Richard R Almon, Stanley H Appel, Science, 182: 927-929, 11/30/1973
Serum Globulin in Myasthenia Gravis: Inhibition of α-bungarotoxin Binding to Acetylcholine Receptors
Richard R Almon, Clifford G Andrew, Stanley H Appel, Science, 185: 55-57, 10/4/1974
Macromolecular Characterization of Muscle Membranes II. Acetylcholine Receptor of Normal and Denervated Muscle
Clifford G Andrew, Richard R Almond, and Stanley H Appel, The Journal of Biological Chemistry, 249: 6163-6165, 10/10/1974
Acetylcholine Receptor in Normal and Denervated Slow and Fast Muscle
Richard R Almon, Clifford G Andrew, Stanley H Appel, Biochemistry, 13: 5522-5530, 12/1/1974
Macromolecular Characterization of Muscle Membranes III. Endogenous Membrane Kinase and Phosphorylated Protein Substrate from Normal and Denervated Muscle.
Clifford G Andrew, Richard R Almon, Stanley H Appel, The Journal of Biological Chemistry, 250: 3972-3980, 5/25/1975
Susceptibility of Skeletal Muscle to Coxsackie A2 Virus Infection: Effects of Botulinum Toxin and Denervation
Clifford G Andrew, Daniel B Drachman, Alan Pestronk, Opendra Narayan, Science, 223: 714-716, 2/17/1984
Join now to see all